Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Firms / T••••• H••••• I••••••••

T••••• H••••• I••••••••

Multi-stage venture firmPalm Beach Gardens, FLt•••••••••.comSEC venture capital fund adviser

T••••• H••••• I•••••••• is a private equity firm that partners with high-growth, commercial-stage healthcare companies and invests in the medical device, healthcare services and technology, specialty pharmaceuticals, and biotechnology sectors. Our investments in people, products, technologies, and services have a significant impact on global health.

both early and growth/opportunity families, reported GAV $70M

Importance
29
moderate
Active deployment
4
low
Emerging
0
low
Completeness
69
high
Freshness
99
high
Research priority
6
low
Identity and regulatory footprint
Headquarters
Palm Beach Gardens, FLadviserinfo.sec.gov
Office address
11770 U.S. HIGHWAY 1 - SUITE 503, Palm Beach Gardens, FL, 33408adviserinfo.sec.gov
Business phone
561-200-3300adviserinfo.sec.gov
SEC adviser type
exempt reporting adviseradviserinfo.sec.gov
SEC exemption claimed
venture capital fund adviseradviserinfo.sec.govItem 2.B(1): advises solely venture capital funds
Latest Form ADV
Mar 30, 2026
Private funds reported
4 (4 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$58.8Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Owners on Schedule A
L• T••••• • S• W••••• T•••• J•••• L• T••••• I••••••••• T•••• U•• D•••• 0••••••••• F•• S••• W••••• (Member Of T••••• H••••• I•••••••• Of Florida Llc), NA; L• T••••• • E• S•••••••• T•••• J•••• L• T••••• I••••••••• T•••• U•• D•••• 0••••••••• F•• E•••••••• S•••••••• (Member Of T••••• H••••• I•••••••• Of Florida Llc), NA; L• T••••• • J••• T••••• T•••• J•••• L• T••••• I••••••••• T•••• U•• D•••• 0••••••••• F•• J••• T••••• (Member Of T••••• H••••• I•••••••• Of Florida Llc), NA
business phone
561-200-3300adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
1 observed deals
Stated (the firm’s website)
Sectors
healthcare, biotech, medtech
Stages
not stated or not yet read
Geography
global
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors
unknown 100%
lead rate n/afollow-on rate n/anew logos, 12 months 1
Funds and vehicles
4 reported, 8 no longer reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
T••••• G••••• F••• I•• L•••Growth fund2019 form d first saleMature$12.1M
Apr 16, 2024
15$16.1MAug 3, 2021
T••••• G••••• F•••• L•••Growth fund2014 form d first saleHarvest$15.4M
Apr 16, 2024
25$21.4M
of $200M
Jan 30, 2015
T••••••••• C•••••• F•••• I••• L•••FundunknownUnknown$33.8M
Apr 16, 2024
35unknownunknown
T••••• G••••• F••• C••••• F•••••• L•••Growth fundunknownUnknown$8.5M
Apr 16, 2024
3unknownunknown
T••••••••• C•••••• F•••• I•• L•••FundunknownWound down$21.0M
Mar 27, 2020
90unknownunknown
T••••••••• C•••••• F•••• I•• L•••FundunknownWound down$21.0M
Mar 27, 2020
90unknownunknown
T• J•••••• C•••••• F•••• L•FundunknownWound down$1.4M
Mar 31, 2014
37unknownunknown
T••••• O••••••••• F•••• L•••Opportunity fundunknownWound down$637,000
Mar 28, 2018
12unknownunknown
T••••• O••••••••• F•••• I•• L••Opportunity fundunknownWound down$619,234
Mar 25, 2019
13unknownunknown
T• J•••••• C•••••• F••• I•• L•••FundunknownWound down$62,976
Mar 27, 2020
2unknownunknown
T• L••••••••• F•••• L•••FundunknownWound down$48,965
Mar 27, 2020
2unknownunknown
T• O••••• C•••••• F•••• L•••FundunknownWound down$36,077
Mar 27, 2020
2unknownunknown
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
18 current, 2 departed
J•••• L••••• L•••• T•••••
Manager / Member Of T••••• H••••• I•••••••• Of Florida, Llc · since Jun 1, 2012
Partner
M•••••• D• M••••••
Chief Accounting Officer Of T••••••••• & Co., Inc. · since Dec 1, 1999
Platform and operations
S•••••••• M•••
Controller Of T••••• H••••• I•••••••• Of Florida Llc · since Aug 1, 2011
Platform and operations
D•••••• G• F•••••
Senior Vice President And Secretary Of T••••••••• & Co., Inc. · since Jun 1, 2008
Vice president
2 departed (kept with end dates)
Investments on record
1 edges, 1 companies, 0 partner-attributed
CompanyRoundRolePartnerRound sizeThis investorDateSource
S•••••portfolio listingunknownunknownunknownunknownSep 16, 2026Fact Venture organization websites (about, team, portfolio, thesis, news pages)
“This investor” is the amount disclosed for this investor alone; it is unknown unless a source said it. The round size is the whole round.
Co-investors
3 relationships from shared deals, counted for the whole firm
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
20 dated events
  1. Mar 29, 2016
    T••••• G••••• F••• C••••• F•••••• L••• first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $16,460,000
  2. Mar 29, 2016
    C••• H• L•••••• (Senior Vice President And Assistant Secretary Of T••••••••• & Co., Inc.) no longer on Schedule A of T••••• H••••• I••••••••
  3. Mar 31, 2015
    T• J•••••• C•••••• F•••• L• no longer reported on Form ADV by T••••• H••••• I••••••••
  4. Mar 31, 2015
    T••••• G••••• F•••• L••• first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $5,828,000
  5. Mar 28, 2013
    N••• M•••• (Chief Financial Officer) no longer on Schedule A of T••••• H••••• I••••••••
  6. Mar 29, 2012
    T••••• O••••••••• F•••• L••• first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $6,157,000
  7. Mar 29, 2012
    T••••••••• C•••••• F•••• I••• L••• first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $33,846,000
  8. Mar 29, 2012
    T••••• O••••••••• F•••• I•• L•• first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $3,950,000
  9. Mar 29, 2012
    T••••••••• C•••••• F•••• I•• L••• first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $17,838,000
  10. Mar 29, 2012
    TD O••••• Capital Fund, LP first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $2,066,000
  11. Mar 29, 2012
    TD L••••••••• Capital Fund, LP first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $17,129,000
  12. Mar 29, 2012
    TD J•••••• Capital Fund II, LP first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $22,278,000
  13. Mar 29, 2012
    T••••• H••••• I•••••••• first filed Form ADV (ERA, venture capital fund adviser exemption)
  14. Mar 29, 2012
    T• J•••••• C•••••• F•••• L• first reported on Form ADV by T••••• H••••• I•••••••• (Venture Capital Fund), GAV $1,297,000
  15. Aug 1, 2011
    S•••••••• M••• joined Schedule A of T••••• H••••• I•••••••• as Controller Of T••••• H••••• I•••••••• Of Florida Llc
  16. Jul 1, 2005
    E•••••••• D• T••••• joined Schedule A of T••••• H••••• I•••••••• as Trustee
  17. Jul 1, 2005
    S••• D•••••• T••••• joined Schedule A of T••••• H••••• I•••••••• as Trustee
  18. Jul 1, 2005
    J••• L••••• T••••• joined Schedule A of T••••• H••••• I•••••••• as Trustee
  19. Jul 1, 2005
    L•••• T••••• joined Schedule A of T••••• H••••• I•••••••• as Trustee
  20. Dec 1, 1999
    M•••••• D• M•••••• joined Schedule A of T••••• H••••• I•••••••• as Chief Accounting Officer / Controller Of T••••••••• & Co., Inc.
Classification history
  1. Sep 15, 2026
    Multi-stage venture firm (confirmed, 95%, cls-1)
    both early and growth/opportunity families, reported GAV $70M
  2. Sep 12, 2026
    Multi-stage venture firm (confirmed, 95%, cls-1)
    both early and growth/opportunity families, reported GAV $54M
Evidence
64 observations from 3 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
Why admittedvc_exemption,vc_funds_reportedMar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserMar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC exemption claimedventure_capital_fund_adviserApr 16, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserMar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
SEC adviser typeexempt_reporting_adviserApr 16, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
SEC adviser typeexempt_reporting_adviserMar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2017-03-29Apr 16, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2012-03-29Mar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2026-03-30Mar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Latest Form ADV filing2024-04-16Apr 16, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2017-03-29Mar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv s•••••ERA - ActiveMar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Adv s••••• effective date2017-03-29Mar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture share of reported funds1Apr 16, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture share of reported funds1Mar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone561-200-3300Mar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Business phone561-200-3300Apr 16, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone561-200-3300Mar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
DescriptionT••••• H••••• I•••••••• is a private equity firm that partners with high-growth, commercial-stage healthcare companies and invests in the medical device, healthcare services and technology, specialty pharmaceuticals, and biotechnology sectors. Our investments in people, products, technologies, and services have a significant impact on global health.
meta description
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
HeadquartersPalm Beach Gardens, FLMar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
HeadquartersPalm Beach Gardens, FLApr 16, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
HeadquartersPalm Beach Gardens, FLMar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address11770 U.S. HIGHWAY 1 - SUITE 503, Palm Beach Gardens, FL, 33408Mar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Office address11770 U.S. HIGHWAY 1 - SUITE 503, Palm Beach Gardens, FL, 33408Apr 16, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address11770 U.S. HIGHWAY 1, SUITE 503, Palm Beach Gardens, FL, 33408Mar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formLimited Liability CompanyMar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Legal formLimited Liability CompanyApr 16, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Legal formCorporationMar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Portfolio pagehttps://t•••••••••.com/
1 entries read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Private funds reported4Mar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private funds reported4Apr 16, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private funds reported9Mar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$58.8MMar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Private fund gross assets (reported)$69.8MApr 16, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$114MMar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated geographyglobal
geography words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorshealthcare,biotech,medtech
sector words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://t•••••••••.com/
10 name/title pairs read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported4Mar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
Venture funds reported4Apr 16, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture funds reported9Mar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
WebsiteHTTP://T•••••funds.com
re-picked from Schedule D 1.I by name
Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
WebsiteHTTP://T•••••funds.comMar 30, 2026FactSEC Form ADV monthly roster (registered + exempt reporting advisers)
WebsiteHTTP://THI-FUNDS.COMApr 16, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
WebsiteHTTP://THI-FUNDS.COMMar 29, 2017FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleRepeatable Scalable Commercial H•••••care Investment | Medical Device | H•••••care Technology | Specialty Pharmaceuticals | Biotechnology| H•••••care Services | T••••• H••••• I••••••••
title tag
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)